Menstrual Cycle Abnormal
8
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents
Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
Quantum Menstrual Health Monitoring Study
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women
Stellate Ganglion Block to Treat Long COVID 19 Case Series
Evaluation of Risk Factors for Gestational Diabetes Mellitus